Acute Myocarditis:Diagnosis and Management
description
Transcript of Acute Myocarditis:Diagnosis and Management
![Page 1: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/1.jpg)
ACUTE MYOCARDITIS
; ITS DIAGNOSIS
AND MANAGEMEN
T
SEMINAR 17/07/2013DR PAWAN KUMAR OLA
![Page 2: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/2.jpg)
DEFINITION AND INCIDENCE
![Page 3: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/3.jpg)
Acute myocarditis is an inflammatory disease of the heart muscle that may progress to dilated cardiomyopathy and chronic heart failure.
Myocarditis may present with a wide range of symptoms, ranging from mild dyspnea or chest pain that resolves without specific therapy to cardiogenic shock and death.
DCM with chronic heart failure is the major long-term sequela of myocarditis.
![Page 4: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/4.jpg)
According to WHO/ISFC myocarditis is an inflammatory disease of the myocardium,diagnosed by established histological,immunological and immunohistochemical criteria.
Three distinct forms of inflammatory cardiomyopathy (myocarditis associated with cardiac dysfunction) are recognised:idiopathic,autoimmune and infectious.
Various infectious agents may cause myocarditis but most common are the viral agents.
Circulation 1996;93:341-2
![Page 5: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/5.jpg)
Classic Dallas criteria for the pathologic diagnosis of myocarditis require the presence of inflammatory cells simultaneous with evidence of myocyte necrosis on the same microscopic section.
Borderline myocarditis is characterized by inflammatory cell infiltrate without myocardial necrosis.
Am J Cardiovasc Pathol 1:3,1987
![Page 6: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/6.jpg)
H&E stain Acute myocarditis showing inflammatory cells with myocyte damage
![Page 7: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/7.jpg)
Dallas criteria are limited by variability in interpretation, lack of prognostic value and low sensitivity.
Alternative pathological classification based on cell-specific immunoperoxidase stains for surface antigen;anti-CD3,anti-CD4,anti-CD20,anti-CD68 anti-HLA.
Criteria based on immunoperoxidase staining have greater sensitivity and may have prognostic value.
Kindermann I et al,Circulation 2008;118:639-48.
Herskowitz et al, JACC 1990;15:624-32
![Page 8: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/8.jpg)
CD3 immunostaining of T lymphocytes in acute myocarditis
Herskowitz et al, JACC 1990;15:624-32
![Page 9: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/9.jpg)
The precise incidence of myocarditis is difficult to ascertain.
Recent pathologic series examining young adults who had suffered sudden death suggested an incidence of myocarditis around 8.6%.
Fabre A,Sheppard MN:Heart 92:316,2006
When patients with idiopathic dilated cardiomyopathy only are considered then myocarditis accounts for 10-40%.
Nugent et al, NEJM 348:1639,2003
![Page 10: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/10.jpg)
CAUSATIVE AGENTS
![Page 11: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/11.jpg)
Viruses are the most common agents.
The spectrum of viruses shifted from coxsackievirus B to adenovirus in the late 1990s.
Enterovirus (1980s) →Adenovirus (1990s) → parvovirus B19 and human herpesvirus 6
Adenoviral infections can be much more virulent than coxsackievirus and can cause extensive cell death without comparable inflammatory response.
Kuhl U et al, Circulation 2005;112:1965-70Mahrholdt H et al, Circulation 2006;114:1581-90
![Page 12: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/12.jpg)
Bowles & coworkers analyzed biopsy specimens from 624 patients with PCR and found overall viral positivity was 38% (239/624).
On analysis,22.8% tested positive for adenovirus, 13.6% for enterovirus and 1% for parvovirus.
Bowles et al, JACC 42:466,2003
![Page 13: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/13.jpg)
Hepatitis C virus agent mainly seen in Asian countries such as Japan (Hepatitis C infection is also overall more prevalent in Asia).
Many of the patients with Hepatitis C myocarditis exhibit a hypertrophic cardiomyopathy phenotype rather than a dilated heart.
![Page 14: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/14.jpg)
Dobutamine may be associated with Eosinophilic myocarditis as a hypersensitivity reaction.
![Page 15: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/15.jpg)
PATOPHYSIOLOGY
![Page 16: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/16.jpg)
Pathogenesis of myocarditis-
Phase 1- cardiac injury and activation of the innate immune response.
Phase 2- acute myocarditis (acquired immune response)
Phase 3- recovery or persistent cardiomyopathy.
N Engl J Med 2009;360:1526-38
![Page 17: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/17.jpg)
Prog Cardiovasc Dis 2010;52:274-288
![Page 18: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/18.jpg)
Viruses enter cardiac myocytes or macrophages through specific receptors and coreceptors.
Receptor for coxsackievirus B and adenovirus 2 &5 is the Human Coxsackie Adenovirus Receptor (CAR).
The virulence of coxsackievirus B is also modified by variations in its viral genome as well as in host factors such as selenium deficiency and mercury exposure.
![Page 19: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/19.jpg)
Innate immune responsedetermines the acquired T
and B cell response.
CD4+T lymphocytes are key mediators of cardiac damage in autoimmune myocarditis.
Circulating CD4+T cells are under the control ofRegulatory T cells (T
reg).
N Engl J Med 2009;360:1526-38
![Page 20: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/20.jpg)
Cardiac injury activates the innate immune mechanisms like TLR2 & TLR4.
They induce proinflammatory cytokines like TNF and IL-1β.
They directly alter cardiac function and promote extracellular matrix remodelling,resulting in fibrosis and cardiac dilation.
TLR3 & TLR9 reduce acute myocarditis while TLR2 & TLR4 which increase viral replication and immune response to infection,increase disease.
Heart 2012;98:835-840
![Page 21: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/21.jpg)
CLINICAL PRESENTATION
![Page 22: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/22.jpg)
Clinical presentation can range from asymptomatic ECG or ECHO findings to cardiac dysfunction, arrhythmias or heart failure and hemodynamic collapse.
Myocarditis typically has a bimodal distribution in terms of age in the population.
Acute presentation is common in young children. In contrast,the presenting symptoms are more subtle and insidious,often with DCM and heart failure,in the older adult population.
![Page 23: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/23.jpg)
Acute myocarditis Fulminant myocarditis Giant cell myocarditis Chronic active myocarditis Eosinophilic myocarditis Peripartum cardiomyopathy
![Page 24: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/24.jpg)
The viral prodrome of fever, chills, myalgia and constitutional symptoms occur in 20-80% of cases so can be missed by the patient and thus can not be relied on for diagnosis.
Fulminant myocarditis has abrupt onset, usually within 2 weeks of a viral illness.Patients have hemodynamic compromise requiring pressor or mechanical support.
Prognosis of fulminant myocarditis is good.
![Page 25: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/25.jpg)
A total of 147 patients (15 patients fulminant and 132 patients of acute myocarditis) were followed for 5.6 years.
Fulminant myocarditis was an independent predictor of survival after adjusting for age,histopathological findings and hemodynamic variables.
N Engl J Med 2000;342:690-5
![Page 26: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/26.jpg)
P<0.05
Long term transplant free survival did not differ significantly according to the degree of inflammation on biopsy.
For fulminant myocarditis transplant-free survival of 93% in 11 years
N Engl J Med 2000;342:690-5
![Page 27: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/27.jpg)
Giant cell myocarditis have survival less than 6 months and is improved with the use of immunosuppressive therapy.
Giant cell myocarditis often have other autoimmune disorders including thymoma and Crohn disease.
Chronic active myocarditis have insidious onset and occurs in older adults.
Eosinophilic myocarditis is a hypersensitivity to drugs or occurs with systemic eosinophilic disorders.
![Page 28: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/28.jpg)
DIAGNOSIS
![Page 29: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/29.jpg)
EXPANDED CRITERIA FOR DIAGNOSIS OF MYOCARDITIS
Suggestive of myocarditis 2 positive categories
Compatible with myocarditis 3 positive categories
High probability of myocarditis All 4 categories positive
Any matching feature in category =positive for category
![Page 30: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/30.jpg)
CATEGORY I :
Clinical symptoms-
Clinical heart failure Fever Viral prodrome Fatigue Dyspnea on exertion Chest pain Palpitations Presyncope or syncope
![Page 31: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/31.jpg)
CATEGORY II :
Evidence of cardiac structural or functional defect in the absence of regional coronary ischemia-
Echocardiographic evidence of RWMA, cardiac dilation or regional cardiac hypertrophy
Troponin release: High sensitivity (> 0.1 ng/ml) Positive indium In 111 antimyosin scintigraphyAND Normal coronary angiography OR, Absence of reversible ischemia by coronary
distribution on perfusion scan.
![Page 32: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/32.jpg)
CATEGORY III :
Cardiac magnetic resonance imaging-
Increased myocardial T2 signal on inversion recovery sequence
Delayed contrast enhancement after gadolinium-DTPA infusion
![Page 33: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/33.jpg)
CATEGORY IV :
Myocardial biopsy-pathologic or molecular analysis –
Pathologic findings compatible with Dallas criteria
Presence of viral genome by PCR or in situ hybridization.
![Page 34: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/34.jpg)
LABORATORY TESTING
![Page 35: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/35.jpg)
MARKERS OF INFLAMMATION
Non-specific serum markers of inflammation eg.ESR,CRP and leucocyte count are often elevated in myocarditis but seldom used for diagnosis.
Increased serum concentration of cytokines TNFα,IL1β and IL10 predict an increased risk of death in myocarditis patients.
JACC 2004;44:1292-7 Heart 2004;90:464-
70
![Page 36: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/36.jpg)
AUTOANTIBODIES Anti-myosin antibodies are associated with LV
systolic dysfunction and diastolic stiffness in patients with chronic myocarditis.
Lauer B et al,JACC 2000;35:11-18
Anti-β1 receptor antibodies have been associated with greater risk of death or heart transplantation.
Stork S et al,Am Heart J 2006;152:697-704
Approx. 59% patients of myocarditis in one study were found to be positive for heart specific antibodies by immunofluorescence.
Neumann DA et al,JACC 1990;16:839-46
![Page 37: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/37.jpg)
VIRAL SEROLOGY
The diagnostic value of viral serology is limited b/c most viral infections involved in the pathogenesis of myocarditis are highly prevalent in the general population.
![Page 38: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/38.jpg)
TROPONINS
Troponins are more useful when high sensitivity thresholds are used (> 0.1 ng/ml)
A gradual rise of troponins over more than 24 hours,with a peak a day or more after the initial rise,may help distinguish myocarditis from acute ischemic injury.
![Page 39: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/39.jpg)
ELECTROCARDIOGRAPHY
ECG may show sinus tachycardia,non-specific ST-T abnormalities,ST elevation or pathologic Q waves.
Sensitivity of ECG for myocarditis is low (47%). Am Heart J1992;124:455-67
Widened QRS and presence of Q waves are associated with higher rates of cardiac death or heart transplantation.
Nakasima et al,Intern Med 1994;33:659-66 Nakasima et al,Jpn Heart J 1998;39:763-74
![Page 40: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/40.jpg)
ECHOCARDIOGRAPHY
There are no specific ECHO features of myocarditis and it is used mainly to exclude other causes of heart failure.
Impaired right ventricular function is a strong predictor of death or need for cardiac transplantation in a series of 23 patients with biopsy confirmed myocarditis.
Mendes LA et al, Am Heaert J 1994;128;301-7
![Page 41: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/41.jpg)
In the Myocarditis Treatment Trial,increased sphericity and LV volume occurred in acute active myocarditis.
Fulminant myocarditis may be distinguished by a smaller LV cavity size and increased wall thickness.
Myocarditis Treatment Trial.Am Heart J1999;138:303-8
Felker et al, J Am Coll Cardiol 2000;36:227-32
![Page 42: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/42.jpg)
CARDIAC MRI
Cardiac MRI is being used with increasing frequency for noninvasive assessment of patients with suspected myocarditis.
Cardiac MRI can evaluate 3 markers of tissue injury –intracellular & interstitial edema (T2W) hyperemia & capillary leakage (EGE) and necrosis & fibrosis (LGE).
A combination of T1-weighted and T2-weighted images had the best combination of sensitivity and specificity.
![Page 43: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/43.jpg)
A recent consensus report on CMRI in myocarditis states that a cardiac MRI should be performed in symptomatic patients with clinical suspicion of myocarditis.
Three imaging criteria for confirming the diagnosis of myocarditis ( Lake Louise criteria) by cardiac MRI have been proposed.
At least two of the CMR criteria are required for diagnosis of myocardial inflammation.
![Page 44: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/44.jpg)
LAKE LOUISE CRITERIA
1) Regional or global myocardial signaling intensity increase in T2-weighted images.
2) Increased global myocardial early gadolinium enhancement ratio b/w myocardium and skeletal muscle in gadolinium enhancement T1W images.
3) At least one focal lesion with nonischemic regional distribution in inversion recovery prepared gadolinium enhanced T1W images (late gadolinium enhancement).
![Page 45: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/45.jpg)
35 year male without any risk factors presented with 8 hrs of chest pain,he was thrombolysed.Trop T was positive but no RWMA on echocardiography.No culprit lesion on CAG.
![Page 46: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/46.jpg)
Delayed enhanced cardiac MRI showed extensive hyper-enhancement sparing sub-endocardium and not matching any coronary artery territory.
![Page 47: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/47.jpg)
Temporal evolution of the distribution and severity of LGE in acute myocarditis.
![Page 48: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/48.jpg)
![Page 49: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/49.jpg)
![Page 50: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/50.jpg)
Contrast cardiac MRI may be used to direct Endomyocardial biopsy.
In this study by Mahrholdt et al,histopathological evaluation of biopsy directed by contrast cardiac MRI with LGE revealed active myocarditis in 19 of 21 patients.
In contrast,when biopsy could not be obtained from the region of contrast enhancement,active myocarditis was found in only 1 of 11 patients.s
Mahrholdt H et al, Circulation 2004;109:1250-58
![Page 51: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/51.jpg)
Interestingly,CMR suggested that the lateral wall may actually be the most common location for lesion development,not the septum, from which most of the biopsy samples have been taken previously.
![Page 52: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/52.jpg)
ENDOMYOCARDIAL BIOPSY
Despite insensitivity for detection of myocarditis, the Dallas criteria remain the gold standard for unequivocal diagnosis.
Chow and McManus demonstrated that with a single EMB sample,histologic myocarditis could be demonstrated in only 25% of cases.Even with 5 random samples,correct diagnosis by classic Dallas criteria could be reached in only about 2/3rd of subjects.
![Page 53: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/53.jpg)
Recently ACC/ESC guidelines have described 2 clinical scenarios which has class I recommendation for endomyocardial biopsy.
First is the classic presentation of fulminant myocarditis,ie. unexplained new-onset heart failure symptoms < 2 weeks in duration associated with normal or dilated LV and hemodynamic compromise.
Circulation 2007;116:2216-2233
![Page 54: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/54.jpg)
Second scenario describes Giant cell myocarditis, ie.unexplained new-onset heart failure symptoms 2 weeks to 3 months in duration associated with a dilated LV and new ventricular arrhythmias,high degree AV block or failure to respond to usual care within 1 to 2 weeks.
![Page 55: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/55.jpg)
DIAGNOSTIC MODALITY SENSITIVITY RANGE (%)
SPECIFICITY RANGE (%)
Electrocardiographic changes (AV block; Q wave, ST changes) 47 ?
Troponin (lower threshold of >0.1 ng/mL) 34-53 89-94
Creatine kinase MB isoform 6 ?
Antibodies to virus or myosin 25-32 40
Indium 111 antimyosin scintigraphy 85-91 34-53
Echocardiography (ventricular dysfunction) 69 ?
Cardiac magnetic resonance 86 95
Myocardial biopsy (Dallas criteria of pathology) 35-50 78-89
Myocardial biopsy (viral genome by PCR) 38-65 80-100
![Page 56: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/56.jpg)
MANAGEMENT
![Page 57: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/57.jpg)
The first line of therapy for all patients with myocarditis and heart failure is supportive care.
![Page 58: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/58.jpg)
IMMUNOSUPPRESSION
![Page 59: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/59.jpg)
111 patients of myocarditis and LVEF < 45% were randomly assigned to conventional therapy alone or combined with 24 weeks of immunosuppressive therapy.
![Page 60: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/60.jpg)
![Page 61: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/61.jpg)
N Engl J Med 1997;336:1860-6
![Page 62: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/62.jpg)
N Engl J Med 1997;336:1860-6
![Page 63: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/63.jpg)
These studies suggest that immunosuppression is not beneficial in the routine treatment of acute lymphocytic myocarditis.
But,transplant-free survival in patients with giant-cell myocarditis may be prolonged with a combination of cyclosporine and corticosteroids.
Recommendation of HFSA 2010 guidelines-
Routine use of immunosuppressive therapies is not recommended for patients with myocarditis. (Strength of Evidence = A)
![Page 64: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/64.jpg)
INTRAVENOUS IMMUNE GLOBULIN
![Page 65: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/65.jpg)
McNamara DM et al.Circulation 2001;103:2254-9 (IMAC II trial)
![Page 66: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/66.jpg)
Therefore,the routine use of IVIG for acute myocarditis in adults is not recommended.
McNamara DM et al.Circulation 2001;103:2254-9 (IMAC II trial)
![Page 67: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/67.jpg)
Drucker NA et al.Circulation 1994;89:252-7
![Page 68: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/68.jpg)
So, the IVIG may have a role in the treatment of acute pediatric myocarditis.
Drucker NA et al.Circulation 1994;89:252-7
![Page 69: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/69.jpg)
INTERFERON
![Page 70: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/70.jpg)
![Page 71: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/71.jpg)
![Page 72: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/72.jpg)
Other approaches to modify immune activation like immunoadsorption and immunomodulation are under investigation.
![Page 73: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/73.jpg)
SUMMARY
![Page 74: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/74.jpg)
Acute myocarditis is an inflammatory disease of the heart muscle that may progress to dilated cardiomyopathy and chronic heart failure.
The clinical presentation of acute myocarditis is non-specific.
Suspected myocarditis is currently confirmed using advanced non-invasive imaging and histopathologic examination.
![Page 75: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/75.jpg)
With the understanding of new pathophysiologic mechanisms new therapies like interferon and immune-modifying strategies are under investigation.
![Page 76: Acute Myocarditis:Diagnosis and Management](https://reader033.fdocuments.us/reader033/viewer/2022061103/53fb77c08d7f729c2e8b5849/html5/thumbnails/76.jpg)
THANKS